A Prospective Randomized Study for Efficacy of Uncovered Double Bare Metallic Stent Compared to Uncovered Single Bare Metallic Stent in Malignant Biliary Obstruction
Not Applicable
Completed
- Conditions
- Malignant Biliary Obstruction
- Interventions
- Procedure: metallic biliary stent insertion (double bare - S&G Biotech.)Procedure: metallic biliary stent insertion (single bare - S&G Biotech.)Procedure: metallic biliary stent insertion (single bare - Taewoong Medical.)
- Registration Number
- NCT01869894
- Lead Sponsor
- Yonsei University
- Brief Summary
Our study is the prospective randomized study for efficacy of uncovered double bare metallic stent compared to uncovered single bare metallic stent in malignant biliary obstruction
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 73
Inclusion Criteria
- The patients who had malignant biliary obstruction
Read More
Exclusion Criteria
- The patients who had resectable biliary malignancy
- The patients who had hilar obstruction
- The patients who had duodenal obstruction
- The patients who had other malignancy which is not related to biliary obstruction
- The patients who had uncontrolled infection
- The patients who had poor performance (ECOG =3 or 4)
- The patients who were not acquired informed consent
- The patients who had technically difficult structure for ERCP
Read More
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description uncovered double bare metallic stent (S&G Biotech.) metallic biliary stent insertion (double bare - S&G Biotech.) uncovered double bare metallic stent uncovered single bare metallic stent (S&G Biotech.) metallic biliary stent insertion (single bare - S&G Biotech.) uncovered single bare metallic stent uncovered single bare metallic stent (Taewoong Medical.) metallic biliary stent insertion (single bare - Taewoong Medical.) uncovered single bare metallic stent
- Primary Outcome Measures
Name Time Method Median patency duration Approximately 6 months later since the date of stent insertion Primary end point : A. Median patency duration
- Secondary Outcome Measures
Name Time Method 6-months patency rate Approximately 6 months later since the date of stent insertion Secondary end point : A. 6-months patency rate
Trial Locations
- Locations (1)
Severance Hospital, Yonsei University Health System
🇰🇷Seoul, Korea, Republic of